The variability of Vipera ammodytes ammodytes venoms from Croatia -: biochemical properties and biological activity

被引:25
作者
Balija, ML [1 ]
Vrdoljak, A [1 ]
Habjanec, L [1 ]
Dojnovic, B [1 ]
Halassy, B [1 ]
Vranesic, B [1 ]
Tomasic, J [1 ]
机构
[1] Inst Immunol Inc, HR-10000 Zagreb, Croatia
来源
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY | 2005年 / 140卷 / 02期
关键词
snake venom; fipera ammodytes ammodytes; anticomplementary activity; immunogenicity of snake venom; phospholipase A(2); minimum haemorrhagic dose (MHD); minimum necrotizing dose (MND); lethal activity (LD50);
D O I
10.1016/j.cca.2005.02.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Vipera ammodytes ammodytes venom has been used for many years in Croatia for immunization of horses and production of specific therapeutic antivenoms. The neutralizing effectiveness of antivenoms is directly dependent on the properties of the snake venom used for immunization. Therefore, appropriate characterization of the whole venom is necessary prior to use in the immunization procedure. In the course of such analyses, the variability in biochemical properties and biological activity was observed in venoms collected from snakes originating from different parts of Croatia. The venom pools also differed with respect to time of snake collection (1992-2003). Analyses of three samples of whole venom pools were carried out revealing differences in lethal activity (LD50), minimum haemorrhagic dose (MHD), minimum necrotizing dose (MND), phospholipase A(2) activity and in anticomplementary activity. SDS-PAGE electrophoretic patterns were similar, but not identical, for all tested venom pools with respect to the number of protein bands detected, but intensity of particular components differed. Preliminary immunogenicity testing in terms of determination of specific antibodies revealed similar immunogenicity and high cross-reactivity for three samples tested. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:257 / 263
页数:7
相关论文
共 35 条
[1]  
ALPER CA, 1979, HDB EXPT PHARM, P863
[2]  
BALLOW M, 1969, J IMMUNOL, V103, P944
[3]   Pharmacological characterization and neutralization of the venoms used in the production of Bothropic antivenom in Brazil [J].
Camey, KU ;
Velarde, DT ;
Sanchez, EF .
TOXICON, 2002, 40 (05) :501-509
[4]   Electrophoretic profiles and biological activities: Intraspecific variation in the venom of the Malayan pit viper (Calloselasma rhodostoma) [J].
Daltry, JC ;
Ponnudurai, G ;
Shin, CK ;
Tan, NH ;
Thorpe, RS ;
Wuster, W .
TOXICON, 1996, 34 (01) :67-79
[5]  
de Roodt AR, 1999, J VENOM ANIM TOXINS, V5, P67
[6]  
Debogovic Z., 1981, Veterinarski Arhiv, V51, P34
[7]  
Finney D.J., 1977, PROBIT ANAL, VIII
[8]   Intraspecific variation in the venoms of the South American rattlesnake (Crotalus durissus terrificus) [J].
Francischetti, IMB ;
Gombarovits, MEC ;
Valenzuela, JG ;
Carlini, CR ;
Guimaraes, JA .
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY, 2000, 127 (01) :23-36
[9]   Effectiveness of snake antivenom:: Species and regional venom variation and its clinical impact [J].
Fry, BG ;
Winkel, KD ;
Wickramaratna, JC ;
Hodgson, WC ;
Wüster, W .
JOURNAL OF TOXICOLOGY-TOXIN REVIEWS, 2003, 22 (01) :23-34
[10]  
Gasmi Ammar, 1994, Natural Toxins, V2, P44, DOI 10.1002/nt.2620020109